Skip to content

Low Level Light Therapy (LLLT) for Hair Growth

The Efficacy of Visible Red Light for Promoting the Growth of Human Scalp Hair for Both Male and Female - An Open-label Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03938948
Enrollment
62
Registered
2019-05-06
Start date
2019-04-11
Completion date
2022-12-31
Last updated
2021-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Pattern Baldness, Male Pattern Baldness

Brief summary

A total of 62 participants will receive red light (660 nm) to the scalp through a specially designed light therapy device integrated into a conventional hat. Each treatment will be 30 min per session applied on every other day for 14 weeks.

Interventions

DEVICElow-level laser/light therapy

Participants will wear light therapy devices for 14 weeks

Sponsors

Awareable Technologies Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female subjects between the ages of 18 and 60 years * Diagnosed AGA in the past 12 months for male (Fitzpatrick I-IV, Hamilton-Norwood IIa-V ) and female (Fitzpatrick I-IV, and Ludwig-Savin Baldness Scale I-2, I-3, I-4, II-1, II-2 baldness patterns)

Exclusion criteria

* Known Photosensitivity * Using any oral or topical substance for hair growth * Having Tattoo, hair transplantation, scalp reduction, malignancy or hair weave in the scalp are with alopecia * Known medical conditions that could negatively affect hair growth, such as infections, connective tissue disease * Currently or plan to be on a calorie-restricted diet during study participation

Design outcomes

Primary

MeasureTime frameDescription
Hair Density14 weeksIndividual participant's hair density will be measured at the end of 14 weeks and compared with the baseline density measure at the start of the treatment.

Secondary

MeasureTime frameDescription
Hair Follicle Change14 weeksBoth individual and all participants' follicles shall be analyzed to determine the percent of change in hair follicle anagen/telogen ratio

Countries

United States

Contacts

Primary ContactElinor Chang
admin@awareable.ai7134876230

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026